Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ingria Pratama Capitalindo Tbk. (GRIA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Ingria Pratama Capitalindo Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Ingria Pratama Capitalindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Ingria Pratama Capitalindo Tbk. trades at Rp110 (market cap 811.33B, 10.51M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Ingria Pratama Capitalindo Tbk. is far larger — about 4.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Ingria Pratama Capitalindo Tbk. is more actively traded (10.51M versus 71K). Which is the better fit depends on your goals.

GRIAOBAT
Market Cap
811.33B167.37B
Volume
10.51M71K
Lot
105.06K710
Turnover
1.19B17.51M
Average Price
113.06246.63
Value
1.19B17.51M
Indicative Equilibrium Price
110246
Indicative Equilibrium Volume
7451

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GRIA
View details
OBAT
View details

About Ingria Pratama Capitalindo Tbk.

PT Ingria Pratama Capitalindo Tbk (the “Company”) was established based on Notarial Deed No. 04 dated 8 May 2013 of Euis Widari, S.H. The Company commenced its operationalactivity with purchases of land in 2017.

Read more on GRIA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT